Pharma Industry

Indian pharma: Ecuador to Guatemala, Caplin Point thrived in a low-competition oasis. Now it wants a bigger pie.


From a humble beginning, Caplin Point has expanded both in size and across distant geographies at a remarkable pace. The company, which currently has a substantial footprint in Central America, wants to foray into new markets. But it could be a long shot, as a model that has worked in small countries could be difficult to replicate in large ones.

In the business of pharmaceuticals, one man’s poison is another’s pill — literally. Even as companies across industries are struggling to make a comeback in the post-pandemic world, Indian pharma companies have been enjoying a dream run on the bourses. Indeed, it’s a great time to be invested in pharma stocks. Sample this: Nearly four out of every five pharma stocks with a market capitalisation of more than INR500 crore are trading above their

  • SAVE

Sign in to read the full article

You’ve got this Prime Story as a Free Gift

Already a Member?

Why ?

  • Sharp Insight-rich, Indepth stories across 20+ sectors

  • Access the exclusive Economic Times stories, Editorial and Expert opinion

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise

Source link